parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Frontiers | Mitochondrial Dysfunction in
Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Frontiers Development of CRISPR Cas9, spin off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing ScienceDirect Parkinson's disease linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons: Neuron Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





